Celebrate the birth of Jesus with a message of healing, courage, and renewed strength. This Christmas, discover how faith, wellness, and love can guide you into a healthier, hope-filled New Year.
Tag: Courage Against Cancer
Over 4,000 people downloaded Courage Against Cancer’s free guides last month. Now, one small $5 donation can help bring life-saving treatments closer to FDA approval — so one day, no child or family will be denied care because of cost.
Categories
Anti Cancer Breakthrough Therapies cancer research Coco the Koala Reports Courage Foundation Projects drug repurposing Drug Repurposing & Innovation Integrative Oncology Insights integrative-oncology Ivermectin MD Anderson Mebendazole Natural Treatments Non-Chemo Cancer Treatments Repurposed Drug Studies Research & Science Research News & Updates
Coco’s Big News: Courage Against Cancer Joins Forces with MD Anderson!
G’day mates — it’s me, Coco the Koala, and I can hardly contain my excitement! Today’s a historic moment for our Courage Against Cancer family. 🧬
We’ve just submitted our very first Sponsored Research Agreement (SRA) to MD Anderson Cancer Center — one of the world’s leading institutions in cancer research. Together, we’re launching a preclinical trial studying ivermectin and mebendazole as potential treatments against ovarian cancer.
It’s the first courageous step toward FDA-approved, non-chemotherapy cancer therapies — and I’m beaming with hope! Stay tuned as we climb this new branch of discovery, one brave leaf at a time.
Stay Courageous, mates. Healing is possible.
— Coco the Koala 🐨
Repurposing existing drugs like ivermectin and mebendazole offers a groundbreaking path forward in the war against cancer. Learn how Courage Against Cancer’s preclinical work on ovarian cancer may help establish the safety, mechanisms, and efficacy of these overlooked therapies — and how you can help us bridge science and compassion in the fight for human healing.
Courage Against Cancer explores how ivermectin and mebendazole — two promising repurposed drugs — may enhance the effectiveness of standard cancer treatments. Learn how our ovarian cancer preclinical study aims to uncover synergistic potential that could redefine the future of integrative oncology.
Courage Against Cancer announces a new preclinical research initiative studying ivermectin and mebendazole against ovarian cancer. Learn what science currently shows about these repurposed antiparasitic drugs — and why this research may change the future of cancer therapy.
A cancer diagnosis often focuses solely on the tumor. But what about the person fighting the battle? Discover how Integrative Oncology is revolutionizing cancer care by combining the best of conventional science with evidence-based complementary therapies to manage side effects, empower patients, and heal the whole person—not just the disease.
Feeling lost after a cancer diagnosis? Find your courage and take control. Explore conventional and non-conventional treatment options tailored to your specific cancer type and stage with our powerful database.
Fenbendazole, a veterinary drug, is sparking hope in cancer care. Early studies show it may shrink tumors by disrupting cancer cell growth, while stories like Joe Tippens’ remission inspire patients. At Courage Against Cancer, we’re exploring its potential as a low-cost, holistic tool. Want detailed protocols? Join our Substack for exclusive guides. Start free with Courageous Beginnings or explore our $1 Courageous Transformation program. Discover Fenbendazole’s promise today! [Read more at courageagainstcancer.org/blog]